These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro activity of the novel ketolide HMR 3647 and comparative oral antibiotics against Canadian respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Hoban DJ, Zhanel GG, Karlowsky JA. Diagn Microbiol Infect Dis; 1999 Sep; 35(1):37-44. PubMed ID: 10529880 [Abstract] [Full Text] [Related]
4. Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay. Pankuch GA, Hoellman DB, Lin G, Bajaksouzian S, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 1998 Nov; 42(11):3032-4. PubMed ID: 9797250 [Abstract] [Full Text] [Related]
10. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia. Ohno A, Ishii Y, Kobayashi I, Yamaguchi K. J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717 [Abstract] [Full Text] [Related]
12. [Comparison of the activity of different macrolides on strains of Haemophilus influenzae]. Ramírez de Arellano JA, Perea EJ. Rev Esp Quimioter; 2000 Sep; 13(3):291-6. PubMed ID: 11086280 [Abstract] [Full Text] [Related]
16. In vitro and in vivo antibacterial activity of modithromycin against streptococci and Haemophilus influenzae. Sato T, Kawai Y, Matsuda H, Tateda K, Kimura S, Ishii Y, Yamaguchi K, Gotoh N. J Antimicrob Chemother; 2011 Jul; 66(7):1547-54. PubMed ID: 21511823 [Abstract] [Full Text] [Related]
17. β-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance. Yamada S, Seyama S, Wajima T, Yuzawa Y, Saito M, Tanaka E, Noguchi N. J Infect Public Health; 2020 Apr; 13(4):497-501. PubMed ID: 31839585 [Abstract] [Full Text] [Related]
18. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Denis A, Agouridas C, Auger JM, Benedetti Y, Bonnefoy A, Bretin F, Chantot JF, Dussarat A, Fromentin C, D'Ambrières SG, Lachaud S, Laurin P, Le Martret O, Loyau V, Tessot N, Pejac JM, Perron S. Bioorg Med Chem Lett; 1999 Nov 01; 9(21):3075-80. PubMed ID: 10560728 [Abstract] [Full Text] [Related]